lithium has been researched along with physostigmine in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (75.76) | 18.7374 |
1990's | 6 (18.18) | 18.2507 |
2000's | 1 (3.03) | 29.6817 |
2010's | 1 (3.03) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belmaker, RH; Ebstein, RP; Oppenheim, G | 1 |
Kuran, W | 1 |
Janowsky, DS; Judd, LL; Pechnick, R; Samples, JR | 1 |
Telford, R; Worrall, EP | 1 |
Evenden, JL; Iversen, SD; Lavis, L | 1 |
Carstens, M; Harvey, B; Taljaard, J | 1 |
Nelson, SR; Padzernik, TL; Terry, JB | 1 |
Gish, BG; Honchar, MP; Sherman, WR; Vogler, GP | 1 |
Jope, RS; Morrisett, RA; Snead, OC | 1 |
Barclay, AM | 1 |
Meredith, TJ; Vale, JA | 1 |
Davis, JM | 1 |
Biederman, GB; Heighington, GA; Milgram, NW; O'Neill, W; Stockman, SM | 1 |
Simpson, LL | 1 |
Kovács, T; Szabó, B | 2 |
Campbell, WR; Davisson, JN; Sangiah, S; Wells, JN; Yim, GK | 1 |
Grewaal, DS; Quastel, JH | 1 |
Dawes, PM; Vizi, ES | 1 |
Illés, P; Knoll, J; Rónai, A; Vizi, ES | 1 |
Ishihara, R | 1 |
Luchins, DJ | 1 |
Honchar, MP; Olney, JW; Sherman, WR | 1 |
Davis, J; DeMet, E; Dysken, M; Halaris, A; Harrow, M; Ostrow, D | 1 |
Daunderer, M | 1 |
Davis, WM; Hatoum, NS | 1 |
Davis, JM; Dysken, MW; Hicks, R; Lazarus, L; Lesser, J; Ripeckyj, A | 1 |
Kikuchi, K; Miyauchi, T; Satoh, S | 1 |
Edelstein, P; Garver, DL; Hirschowitz, J; Kanter, DR; Schultz, JR | 1 |
Amital, D; Belmaker, RH | 1 |
Bymaster, FP; Calligaro, DO; Carter, PA; DeLapp, N; Fink-Jensen, A; Jeppesen, L; Mitch, CH; Peters, SC; Rimvall, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Ward, JS; Whitesitt, CA; Zhang, W | 1 |
Fujii, T; Kawashima, K; Nakai, K; Nakajima, Y | 1 |
Hong, E; Liy-Salmeron, G; Meneses, A; Ponce-Lopez, T | 1 |
2 review(s) available for lithium and physostigmine
Article | Year |
---|---|
Poisoning due to psychotropic agents.
Topics: Acid-Base Imbalance; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Arrhythmias, Cardiac; Benzodiazepines; Butyrophenones; Cardiovascular Diseases; Charcoal; Electrocardiography; Humans; Lithium; Monoamine Oxidase Inhibitors; Phenothiazines; Physostigmine; Psychotropic Drugs; Seizures; Thioxanthenes | 1985 |
The pharmacokinetics of psychotropic medication in the elderly: a review.
Topics: Aged; Alcoholism; Analgesics; Antidepressive Agents, Tricyclic; Barbiturates; Biological Availability; Biotransformation; Chlorpromazine; Drug Interactions; Flurazepam; Humans; Intestinal Absorption; Kidney; Kinetics; Lithium; Monoamine Oxidase Inhibitors; Nitrazepam; Oxazepam; Parasympatholytics; Physostigmine; Propranolol; Psychotropic Drugs; Tobacco Use Disorder | 1981 |
31 other study(ies) available for lithium and physostigmine
Article | Year |
---|---|
Effect of lithium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP.
Topics: Adult; Bipolar Disorder; Cyclic GMP; Depression; Female; Guanylate Cyclase; Humans; Lithium; Male; Physostigmine | 1979 |
[Modern methods of treating Huntington's chorea].
Topics: gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Lithium; Methysergide; Physostigmine; Tetrabenazine | 1976 |
Lethal effects of physostigmine plus lithium in rats.
Topics: Animals; Drug Interactions; Lithium; Male; Physostigmine; Rats; Scopolamine | 1977 |
Cognitive functions in manic-depressives: effects of lithium and physostigmine.
Topics: Bipolar Disorder; Cognition; Humans; Injections, Subcutaneous; Lithium; Physostigmine; Psychological Tests | 1978 |
Blockade of conditioned taste aversion by scopolamine and N-methyl scopolamine: associative conditioning, not amnesia.
Topics: Amnesia; Animals; Ascorbic Acid; Avoidance Learning; Chlorides; Conditioning, Operant; Lithium; Lithium Chloride; Male; N-Methylscopolamine; Neostigmine; Parasympatholytics; Physostigmine; Rats; Rats, Inbred Strains; Scopolamine; Scopolamine Derivatives; Sucrose; Taste | 1992 |
Lithium modulation of cortical cyclic nucleotides: evidence for the Yin-Yang hypothesis.
Topics: Animals; Cerebral Cortex; Cyclic AMP; Cyclic GMP; Lithium; Male; Phosphoric Diester Hydrolases; Physostigmine; Rats; Rats, Inbred Strains; Second Messenger Systems | 1990 |
Effect of LiCl pretreatment on cholinomimetic-induced seizures and seizure-induced brain edema in rats.
Topics: Animals; Brain; Brain Edema; Chlorides; Isoflurophate; Lithium; Lithium Chloride; Male; Organ Specificity; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Reference Values; Seizures | 1990 |
Evidence that phosphoinositide metabolism in rat cerebral cortex stimulated by pilocarpine, physostigmine, and pargyline in vivo is not changed by chronic lithium treatment.
Topics: Animals; Cerebral Cortex; Lithium; Male; Pargyline; Phosphatidylinositols; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Regression Analysis; Stimulation, Chemical; Time Factors | 1990 |
Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid.
Topics: Animals; Arecoline; Chlorides; Dose-Response Relationship, Drug; Drug Synergism; Electroencephalography; Kainic Acid; Lithium; Lithium Chloride; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Status Epilepticus | 1987 |
Psychotropic drugs in the elderly. Selection of the appropriate agent.
Topics: Age Factors; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chlordiazepoxide; Cimetidine; Diazepam; Flurazepam; Haloperidol; Humans; Kinetics; Lithium; Phenothiazines; Physostigmine; Psychotropic Drugs; Thiothixene; Trazodone | 1985 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dihydroergotoxine; Drug Interactions; Electroconvulsive Therapy; Gonadal Steroid Hormones; Guanethidine; Haloperidol; Humans; Lithium; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia; Thiothixene; Thioxanthenes; Vitamins | 1974 |
Memory of conditioned food aversion follows a U-shape function in rats.
Topics: Animals; Avoidance Learning; Conditioning, Operant; Drinking; Lithium; Male; Memory; Models, Neurological; Parasympathetic Nervous System; Physostigmine; Rats; Saccharin; Synapses; Taste; Time Factors | 1974 |
The effects of lithium and physostigmine on rat brain acetylcholinesterase activity.
Topics: Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Tolerance; Lithium; Male; Physostigmine; Rats | 1974 |
Effect of physostigmine on Li uptake of frog sartorius muscle.
Topics: Animals; Anura; Depression, Chemical; In Vitro Techniques; Lithium; Muscles; Physostigmine; Rana esculenta; Sodium; Temperature | 1972 |
Oxime analogs of physostigmine.
Topics: Acetylcholinesterase; Aluminum; Animals; Brain; Cattle; Cholinesterases; Cyclization; Enzyme Activation; Erythrocytes; Indoles; Isomerism; Lithium; Methods; Mice; Oxidation-Reduction; Oximes; Physostigmine | 1973 |
Control of synthesis and release of radioactive acetylcholine in brain slices from the rat. Effects of neurotropic drugs.
Topics: Acetylcholine; Ammonium Chloride; Amobarbital; Animals; Brain; Calcium; Carbon Isotopes; Choline; Cholinesterase Inhibitors; Female; Glutamates; In Vitro Techniques; Insecticides; Lithium; Male; Ouabain; Paraoxon; Physostigmine; Potassium; Protoveratrines; Rats; Sodium; Tetrodotoxin; Thiopental | 1973 |
Acetylcholine release from the rabbit isolated superior cervical ganglion preparation.
Topics: Acetylcholine; Animals; Autonomic Fibers, Postganglionic; Autonomic Fibers, Preganglionic; Choline; Cold Temperature; Electric Stimulation; Epinephrine; Ganglia, Spinal; In Vitro Techniques; Lithium; Norepinephrine; Phentolamine; Physostigmine; Potassium; Rabbits; Tetrodotoxin; Time Factors | 1973 |
Effect of lithium on acetylcholine release and synthesis.
Topics: Acetylcholine; Animals; Atropine; Brain; Brain Chemistry; Ileum; In Vitro Techniques; Lithium; Neurons; Norepinephrine; Ouabain; Physostigmine; Rats; Tetrodotoxin | 1972 |
Effect of physostigmine on sodium efflux of frog muscle.
Topics: Animals; Biological Transport, Active; Choline; Depression, Chemical; In Vitro Techniques; Isotonic Solutions; Lithium; Muscles; Ouabain; Physostigmine; Rana esculenta; Sodium; Sodium Isotopes | 1971 |
Stimuli causing extrusion of polar filaments of Glugea fumiferanae spores.
Topics: Calcium Chloride; Cesium; Chlorides; Cholinesterase Inhibitors; Copper; Cyanides; Fluorides; Gastric Juice; Hydrogen-Ion Concentration; Insecta; Lithium; Mercury; Microsporum; Physostigmine; Potassium; Rubidium; Silver; Sodium; Spores; Stimulation, Chemical; Sulfhydryl Compounds; Temperature | 1967 |
Developments in biological psychiatry: clinical applications to the major psychoses.
Topics: Amphetamine; Antidepressive Agents; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Humans; Hydrocortisone; Lithium; Neurotransmitter Agents; Physostigmine; Psychotic Disorders; Research; Schizophrenia; Tomography, X-Ray Computed | 1982 |
Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats.
Topics: Animals; Atropine; Brain Chemistry; Chlorides; Drug Interactions; Humans; Inositol; Inositol Phosphates; Lithium; Lithium Chloride; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Seizures; Substance-Related Disorders | 1983 |
State dependence of noradrenergic activity in a rapidly cycling bipolar patient.
Topics: Adolescent; Adult; Bipolar Disorder; Chlorpromazine; Circadian Rhythm; Electroconvulsive Therapy; Feedback; Female; Glycols; Humans; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Physostigmine; Receptors, Adrenergic; Receptors, Muscarinic | 1984 |
[Physostigmine as delirium-preventive agent in ambulatory alcohol withdrawal].
Topics: Alcohol Withdrawal Delirium; Alcoholism; Ambulatory Care; Aspartic Acid; Humans; Lithium; Physostigmine; Psychoses, Alcoholic | 1983 |
Synergism of the toxicity of physostigmine and neostigmine by lithium or by a reserpine-like agent (Ro4-1284).
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Adrenergic Fibers; Animals; Central Nervous System; Cholinergic Fibers; Drug Synergism; Lethal Dose 50; Lithium; Male; Neostigmine; Physostigmine; Quinolizines; Rats | 1980 |
Further studies on the potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice.
Topics: Animals; Atropine; Brain; Drug Synergism; Humans; Lithium; Liver; Male; Methamphetamine; Mice; Physostigmine; Scopolamine; Stereotyped Behavior | 1981 |
Physostigmine and lithium response in the schizophrenias.
Topics: Adult; Double-Blind Method; Female; Humans; Infusions, Parenteral; Lithium; Male; Physostigmine; Premedication; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1981 |
Lithium involvement in physostigmine-induced seizures.
Topics: Animals; Humans; Lithium; Physostigmine; Seizures | 1994 |
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
Topics: Animals; Binding, Competitive; Brain Chemistry; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Agents; Cholinesterase Inhibitors; Dihydropyridines; Dose-Response Relationship, Drug; Hydrolysis; Hypothermia; Imines; Lithium; Male; Mice; Mice, Inbred Strains; Muscarinic Agonists; Oximes; Parasympathomimetics; Phosphatidylinositols; Physostigmine; Pilocarpine; Pyridines; Quinuclidines; Radioligand Assay; Salivation; Tacrine; Tetrazoles; Thiadiazoles; Tremor | 1998 |
Enhancement of hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by repeated lithium treatment in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Animals; Cholinesterase Inhibitors; Diet; Hippocampus; Lithium; Male; Microdialysis; Neural Pathways; Parasympathetic Nervous System; Physostigmine; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Synaptic Transmission | 2000 |
Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
Topics: Animals; Conditioning, Classical; Disease Models, Animal; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Hippocampus; Hypoglycemic Agents; Infusions, Intraventricular; Lithium; Male; Memantine; Memory Disorders; Neuroprotective Agents; Physostigmine; Pioglitazone; Prefrontal Cortex; Rats; Rats, Wistar; Statistics, Nonparametric; Streptozocin; Thiazolidinediones | 2011 |